Onychomycosis: Making sense of the assessment of anti-fungal drugs

Acta Dermato-Venereologica

Volumn 78, Issue 1, 1998, Pages 1-4

  Shuster, Sam ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANTIFUNGAL ACTIVITY; DRUG EFFICACY; FUNGUS GROWTH; HUMAN; ONYCHOMYCOSIS; PRIORITY JOURNAL; REVIEW;

ANTIFUNGAL AGENTS; DRUG THERAPY; HUMANS; ONYCHOMYCOSIS;

EID: 0031891537     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015559850135724     Document Type: Review

References (13)

1. Clayton YM. Clinical and mycological diagnosic aspects of onychomycoses and dermatomycoses. Clin Exp Dermatol 1992; 17 (Suppl 1): 37-40.
2. Zaug M, Bergstresser M. Amorofine in the treatment of onychomychoses and dermatomycoses (an overview). Clin Exp Dermatol 1992; 17 (Suppl 1): 61-70.
3. Munro CS, Rees JL, Shuster S. Short duration terbenafine therapy penetrates diseased distal nail by the ventral nailbed, and its effectiveness in onychomycosis. Br J Dermatol 1990; 123: 825.
4. Munro CS, Rees JL, Shuster S. The unexpectedly rapid response of fungal nail infection to short duration therapy. Acta Derm Venereol (Stockh) 1992; 72: 131-133.
5. Van der Schroeff, JG, Cirkel PKS, Crijns MB, van Dijkt JA, Govaert FJ, Groeneweg DA, et al. A randomised treatment duration-finding study of terbinafine in onychomycosis. Br J Dermatol 1992; 126 (Suppl 39): 36-39.
6. Baudraz-Rosselet F, Rakosi T, Wili PB, Kenzelmann R. Treatment of onychomycosis with terbinafine. Br J Dermatol 1992; 126 (Suppl 39): 40-46.
7. Hay RJ, Clayton YM, Moore MK. Comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis. Clin Exp Dermatol 1987; 12: 175-177.
8. Finlay AY. Pharmakinetics of terbinafine in the nail. Br J Dermatol 1992; 126 (Suppl 39): 18-32.
9. Faergemann J, Laufen H. Levels of fluconazole in normal and diseased nails during and after treatment of onychomycoses in toe-nails with fluconazole 150 mg once weekly. Acta Derm Venereol (Stockh) 1996; 76: 219-221.
10. Clayton YM. Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses. Clin Exp Dermatol 1992; 17 (Suppl 1): 37-40.
11. Zaias N, Drachman D. A method for the determination of drug effectiveness in onychomycosis. J Am Acad Dermatol 1983; 9: 912-919.
12. Johnson M. Shuster S. Continuous formation of nail along the bed. Br J Dermatol 1993; 128: 277-280.
13. Zaias N. The movement of the nail bed. J Invest Dermatol 1956; 48: 402-403.